The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) of the National Institutes of Health (NIH) will hold a virtual meeting on June 25 to present and deliberate on their report about gene drive application for disease control. The report aims to assess whether existing biosafety guidance is adequate for contained laboratory research utilizing gene drive technology and to outline conditions, if any, under which NIH could consider supporting field release of gene drive modified organisms.